Related Experiment Video
Updated: Feb 15, 2026

10:59
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
1.8K
The antibody horror show: an introductory guide for the perplexed.
1Translational Biomarkers Research, Translational Innovation Platform - Oncology, Merck KGaA, Frankfurterstr. 250, 64293, Darmstadt, Germany.
New Biotechnology
|January 23, 2018
Summary
Commercial research antibodies often fail, wasting billions. Solutions include recombinant antibodies, unique identification, standardized banking, open-source documentation, and user certification for reliable biological research.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Commercial research-tool antibodies are critical reagents in biological research, yet frequently exhibit poor performance.
- The scientific community expends approximately $2 billion annually on these essential but often unreliable tools.
Purpose of the Study:
- To address the widespread problem of non-functional research antibodies.
- To propose actionable solutions to improve antibody reliability and reproducibility in scientific research.
Main Methods:
- Review of existing literature and common causes of antibody failure.
- Formulation of recommendations based on current scientific platforms and user experiences.
Main Results:
- Identified causes of antibody failure include inadequate identification, insufficient validation by users and suppliers, poor user training, and publisher overload.
- Negative outcomes encompass damaged scientific careers, wasted public funds, and compromised scientific literature.
Conclusions:
- Transitioning to recombinant antibodies can enhance consistency and specificity.
- Implementing obligatory unique identification for antibodies, immunogens, and producers is crucial.
- Establishing centralized international banking for standard antibodies and ligands will improve accessibility and reliability.
- Promoting open-source documentation of user experiences and antibody-user certification can foster accountability and improve research quality.
Related Concept Videos
Antibody Structure
65.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K
Antibody Actions
3.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.0K
Antibody Structure and Classes
9.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.4K
CRISPR
58.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.0K
Affinity and Avidity
39.3K
Overview
39.3K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

